1-7 of 7
Jörg Wischhusen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells

Free
Florian Reim, Yvonne Dombrowski, Cathrin Ritter, Mathias Buttmann, Sebastian Häusler, Monika Ossadnik, Mathias Krockenberger, Dagmar Beier, Christoph P. Beier, Johannes Dietl, Jürgen C. Becker, Arnd Hönig, Jörg Wischhusen
Journal: Cancer Research
Cancer Res (2009) 69 (20): 8058–8066.
https://doi.org/10.1158/0008-5472.CAN-09-0834
Published: 14 October 2009
View articletitled, Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells
Open the PDF for Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells in another window
Journal Articles

Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma

Free
Dagmar Beier, Stefanie Röhrl, Deepu R. Pillai, Stefanie Schwarz, Leoni A. Kunz-Schughart, Petra Leukel, Martin Proescholdt, Alexander Brawanski, Ulrich Bogdahn, Ariane Trampe-Kieslich, Bernd Giebel, Jörg Wischhusen, Guido Reifenberger, Peter Hau, Christoph P. Beier
Journal: Cancer Research
Cancer Res (2008) 68 (14): 5706–5715.
https://doi.org/10.1158/0008-5472.CAN-07-6878
Published: 15 July 2008
View articletitled, Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
Open the PDF for Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma in another window
Includes: Supplementary data
Journal Articles

CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles

Free
Dagmar Beier, Peter Hau, Martin Proescholdt, Annette Lohmeier, Jörg Wischhusen, Peter J. Oefner, Ludwig Aigner, Alexander Brawanski, Ulrich Bogdahn, Christoph P. Beier
Journal: Cancer Research
Cancer Res (2007) 67 (9): 4010–4015.
https://doi.org/10.1158/0008-5472.CAN-06-4180
Published: 04 May 2007
View articletitled, CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles
Open the PDF for CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles in another window
Includes: Supplementary data
Journal Articles

Regeneration and Tolerance Factor: A Novel Mediator of Glioblastoma-Associated Immunosuppression

Free
Patrick Roth, Steffen Aulwurm, Isabella Gekel, Dagmar Beier, Roxanne G. Sperry, Michel Mittelbronn, Richard Meyermann, Kenneth D. Beaman, Michael Weller, Jörg Wischhusen
Journal: Cancer Research
Cancer Res (2006) 66 (7): 3852–3858.
https://doi.org/10.1158/0008-5472.CAN-05-3062
Published: 03 April 2006
View articletitled, Regeneration and Tolerance Factor: A Novel Mediator of Glioblastoma-Associated Immunosuppression
Open the PDF for Regeneration and Tolerance Factor: A Novel Mediator of Glioblastoma-Associated Immunosuppression in another window
Journal Articles

SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells In vitro and In vivo

Free
Martin Uhl, Steffen Aulwurm, Jörg Wischhusen, Markus Weiler, Jing Ying Ma, Ramona Almirez, Ruban Mangadu, Yu-Wang Liu, Michael Platten, Ulrich Herrlinger, Alison Murphy, Darren H. Wong, Wolfgang Wick, Linda S. Higgins, Michael Weller
Journal: Cancer Research
Cancer Res (2004) 64 (21): 7954–7961.
https://doi.org/10.1158/0008-5472.CAN-04-1013
Published: 01 November 2004
View articletitled, SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells In vitro and In vivo
Open the PDF for SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells In vitro and In vivo in another window
Journal Articles

RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity In vivo

Free
Manuel A. Friese, Jörg Wischhusen, Wolfgang Wick, Markus Weiler, Günter Eisele, Alexander Steinle, Michael Weller
Journal: Cancer Research
Cancer Res (2004) 64 (20): 7596–7603.
https://doi.org/10.1158/0008-5472.CAN-04-1627
Published: 15 October 2004
View articletitled, RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity In vivo
Open the PDF for RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity In vivo in another window
Journal Articles

Identification of CD70-mediated Apoptosis of Immune Effector Cells as a Novel Immune Escape Pathway of Human Glioblastoma

Free
Jörg Wischhusen, Gundram Jung, Ivan Radovanovic, Christoph Beier, Joachim P. Steinbach, Andreas Rimner, Huatao Huang, Jörg B. Schulz, Hiroko Ohgaki, Adriano Aguzzi, Hans-Georg Rammensee, Michael Weller
Journal: Cancer Research
Cancer Res (2002) 62 (9): 2592–2599.
Published: 01 May 2002
View articletitled, Identification of CD70-mediated Apoptosis of Immune Effector Cells as a Novel Immune Escape Pathway of Human Glioblastoma
Open the PDF for Identification of CD70-mediated Apoptosis of Immune Effector Cells as a Novel Immune Escape Pathway of Human Glioblastoma in another window